Structure−Activity Relationships of (S,Z)-2-Aminopurine Methylenecyclopropane Analogues of Nucleosides. Variation of Purine-6 Substituents and Activity against Herpesviruses and Hepatitis B Virus-Reference-Cited by-同舟云学术

Structure−Activity Relationships of (S,Z)-2-Aminopurine Methylenecyclopropane Analogues of Nucleosides. Variation of Purine-6 Substituents and Activity against Herpesviruses and Hepatitis B Virus

Published:2003-03-15 Issue:8 Volume:46 Page:1531-1537
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Chen Xinchao¹,Kern Earl R.¹,Drach John C.¹,Gullen Elizabeth¹,Cheng Yung-Chi¹,Zemlicka Jiri¹

Affiliation:

1. Department of Chemistry, Developmental Therapeutics Program, Barbara Ann Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, Michigan 48201-1379; Department of Pediatrics, The University of Alabama at Birmingham, Birmingham, Alabama 35294; Department of Biologic and Materials Sciences, School of Dentistry, University of Michigan, Ann Arbor, Michigan 48019-1078; and Department of Pharmacology, Yale University School of Medicine, New Haven, Connecticut 06510-8066

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/jm0205245

Reference19 articles.

1. Effective treatment of murine cytomegalovirus infections with methylenecyclopropane analogues of nucleosides

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Enantioselective Synthesis of Chiral Carbocyclic Nucleosides via Palladium‐Catalyzed Asymmetric Allylic Amination of Alicyclic MBH Adducts with Purines;Advanced Synthesis & Catalysis;2020-04-03

2. The discovery and development of filociclovir for the prevention and treatment of human cytomegalovirus-related disease;Antiviral Research;2020-04

3. Site-selective remote C(sp3)–H heteroarylation of amides via organic photoredox catalysis;Nature Communications;2019-10-18

4. Novel Therapeutics for Epstein–Barr Virus;Molecules;2019-03-12

5. New therapies for human cytomegalovirus infections;Antiviral Research;2018-11